CH ENV TECH & BIO(01237)

Search documents
中科生物(01237) - 2022 - 年度财报
2023-04-28 11:57
Financial Performance - Revenue for the year ended December 31, 2022, was RMB 465,037,000, a decrease of 23.5% from RMB 608,074,000 in 2021[12] - Gross profit for 2022 was RMB 53,873,000, down 55.7% from RMB 121,684,000 in 2021[12] - Loss before tax from continuing operations was RMB 7,143,000 compared to a profit of RMB 38,171,000 in 2021[12] - The net loss for the year from continuing operations was RMB 6,784,000, a significant decline from a profit of RMB 48,324,000 in 2021[12] - Basic loss per share for 2022 was RMB 0.008, compared to earnings of RMB 0.057 per share in 2021[14] Revenue Breakdown - Revenue from the manufacturing and sales of wooden products decreased by 23.4% to RMB 460.7 million in 2022, down from RMB 602.0 million in 2021[25] - The renewable energy segment reported a revenue decline of 29.7% to RMB 4.3 million in 2022, compared to RMB 6.1 million in 2021[26] - Revenue from timber houses and related parts decreased by 22.9% to RMB 412.9 million, representing 89% of total sales for the reporting year[29] - Overall revenue from leisure household products fell by 27.7% to RMB 47.8 million in 2022, down from RMB 66.2 million in 2021[30] - Revenue distribution showed a significant decline in North America, dropping by 68.9% to RMB 12.8 million in 2022[23] Expenses and Costs - Selling and distribution expenses increased to RMB 35,533,000 in 2022 from RMB 46,860,000 in 2021[12] - Administrative expenses decreased to RMB 48,028,000 in 2022 from RMB 62,155,000 in 2021[12] - Gross profit decreased to approximately RMB 53.9 million, down from RMB 121.7 million in 2021, with a gross margin of 11.6% compared to 20.0% in 2021, primarily due to unfavorable pricing conditions of construction materials[33][40] - Selling and distribution expenses were RMB 35.5 million, down from RMB 46.9 million in 2021, attributed to a decrease in turnover and number of shipments[36][43] - Administrative expenses decreased to RMB 48.0 million from RMB 62.2 million in 2021, mainly due to reduced research and development costs[37][44] Assets and Liabilities - Total assets as of December 31, 2022, were RMB 1,016.6 million, an increase from RMB 989.4 million in 2021[18] - Total liabilities increased to RMB 136.2 million in 2022 from RMB 114.0 million in 2021[18] - As of December 31, 2022, current assets were RMB 562.6 million, an increase from RMB 524.3 million in 2021, with cash and cash equivalents rising to RMB 113.8 million from RMB 61.7 million[47][52] - The Group's total equity increased slightly to RMB 879.5 million in 2022 from RMB 869.9 million in 2021[18] Corporate Governance - The company has maintained compliance with the Corporate Governance Code throughout the year, except for certain deviations disclosed in the report[68] - The Board consists of two executive Directors and three independent non-executive Directors, ensuring a strong independent perspective in decision-making[84] - Independent non-executive Directors possess expertise in accounting, finance, and business, contributing to high standards of compliance in financial reporting[91] - The Board is expected to meet at least four times a year, but only held two regular meetings during the year[79] - Each executive Director has a service contract for three years, starting from June 15, 2021, with a notice period of three months for termination[93] Risk Management - The Group has established effective risk management and internal control systems, reviewed annually, ensuring adequate protection against significant misstatements or losses[175] - The Board is responsible for evaluating risks associated with achieving the Group's strategic objectives and maintaining effective risk management systems[173] - The Risk Management Committee reviewed the Group's risk management framework, including risk appetite and policies, to ensure effective risk control[153] - The Company reported no material uncertainties affecting its ability to continue as a going concern[156] - The Company has a system in place for Directors to make inquiries and provide feedback if they miss monthly updates[158] Employee and Workplace - The Group recognizes employee accomplishments by offering comprehensive benefit packages and career development opportunities[200] - The Group ensures a healthy and safe workplace, with no strikes or fatal workplace accidents reported during the year[200] - The Group employed a total of 149 full-time employees as of December 31, 2022, down from 383 in 2021, focusing on increasing production process automation and staff training[58][60] Environmental Responsibility - The Group is committed to minimizing its carbon footprint and has implemented practices such as duplex printing and efficient paper use to reduce environmental impact[187] - The Group's electricity consumption is identified as a significant environmental concern, with efforts to reduce energy usage through conservation practices[191] - The Group closely monitors changes in government policies and regulations, ensuring compliance to avoid penalties or operational disruptions[193] Audit and Compliance - The Audit Committee has recommended the reappointment of CWK CPA Limited as the external auditors of the Company[123] - The Audit Committee reviewed the annual results for the year ended December 31, 2021, and the interim results for the six months ended June 30, 2022[123] - The Audit Committee confirmed the independence and objectivity of the independent auditor, CWK, which received approximately HKD898,000 for audit services during the Year[164][169] - The Audit Committee monitors the external auditor's independence and the effectiveness of the audit process[121]
中科生物(01237) - 2022 - 年度业绩
2023-03-31 13:18
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責 ,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公佈全部或任 何部份內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 CHINA ENVIRONMENTAL TECHNOLOGY AND BIOENERGY HOLDINGS LIMITED 中 科 生 物 控 股 有 限 公 司 (於開曼群島註冊成立之有限公司) (股份代號:1237) 截至二零二二年十二月三十一日止年度的全年業績 中科生物控股有限公司(「本公司」)之董事(「董事」)會(「董事會」)欣然 提呈本公司及其附屬公司(統稱「本集團」)截至二零二二年十二月三十一日止年 度(「二零二二年」或「報告年內」)之經審核綜合年度業績連同二零二一年同期 之比較數字。 ...
中科生物(01237) - 2022 - 中期财报
2022-09-21 09:14
Revenue Performance - The Group's revenue increased by 19.3% to RMB300.9 million during the six months ended June 30, 2022, compared to RMB252.1 million in the same period last year[9]. - Revenue from the manufacturing and sales of wooden products rose by 19.6% to RMB298.0 million, accounting for 99.1% of total revenue[17]. - Revenue from timber products increased by 19.0% to RMB251.4 million, accounting for 83.6% of total sales during the period[30]. - Revenue from the renewable energy business remained stable at approximately RMB2.8 million, compared to RMB3.0 million in the previous year[34]. - Revenue from the PRC market rebounded to approximately RMB46.6 million, representing 15% of total revenue, up from 2% in the previous year[25]. - Revenue from North America decreased significantly to approximately RMB11.9 million, accounting for 4% of total revenue, down from 22% in the previous year[26]. - Revenue from Australasia increased by 29% to approximately RMB220.7 million, representing 74% of total revenue[22]. - Revenue from continuing operations for the six months ended June 30, 2022, was RMB 300,862,000, an increase of 19.3% compared to RMB 252,108,000 for the same period in 2021[180]. Profitability and Margins - The gross profit margin decreased to 9.5% from 14.6% in the previous year, with a gross profit of RMB28.5 million compared to RMB36.9 million in the prior period[9]. - The Group reported a segment loss of RMB396,000 in the wooden products segment, compared to a profit of RMB10.3 million in the previous year[17]. - The Group recorded a profit of approximately RMB 2.1 million for the period, compared to a loss of RMB 4.2 million in the first half of 2021[45][51]. - Profit for the period was RMB 2,140,000, down 49.6% from RMB 4,249,000 in the previous year[131]. - Basic and diluted earnings per share decreased to RMB 0.0025, down from RMB 0.0053 in 2021[128]. Expenses and Costs - Selling and distribution expenses increased by 78.6% to RMB10.0 million due to enhanced marketing efforts and increased shipping costs[37]. - Administrative expenses decreased to RMB 22.3 million from RMB 36.3 million in the first half of 2021, mainly due to a significant reduction in head office and corporate expenses[42][48]. - Finance costs rose to approximately RMB 0.6 million from RMB 0.1 million in the first half of 2021, primarily representing interest payments for bank loans and debentures[43][49]. - Cost of inventories for the six months ended June 30, 2022, increased to RMB 272,357,000 from RMB 215,234,000 in 2021, reflecting a rise of 26.5%[188]. Cash Flow and Financial Position - Cash generated from operating activities was RMB 146,367,000, a significant improvement compared to a cash outflow of RMB 35,458,000 in the same period of 2021[140]. - The net cash used in investing activities was RMB 84,739,000, contrasting with a net cash inflow of RMB 6,648,000 in the prior year[141]. - The company had cash and cash equivalents of RMB 80,095,000 as of June 30, 2022, down from RMB 165,441,000 at the end of June 2021[141]. - The Group had current assets of RMB 493.2 million, down from RMB 524.3 million as of December 31, 2021[46][52]. - Total banking facilities utilized amounted to RMB 9.8 million as of June 30, 2022, a significant decrease from RMB 74 million as of December 31, 2021[47][52]. Market and Strategic Developments - The Group's successful expansion in Australia has been a key driver for revenue growth in the wooden products segment[17]. - The Group's strategic shift towards Australasian markets aims to mitigate the impact of trade protectionism in the United States[17]. - The Group continues to adapt its business strategies in response to market conditions and competitive pressures[9]. - The Group's renewable energy business focuses on recycling leftover sawdust into biomass pellet fuel, maintaining stable revenue levels[18]. Share Capital and Ownership - On August 22, 2022, the Company agreed to issue 35,501,048 new shares at HK$0.0768 per share, representing 7.71% of the enlarged share capital, to convert bond repayment into share capital[72]. - As of June 30, 2022, Mr. Wu Zheyan held a total of 106,954,078 shares, representing 12.58% of the total shareholding[79]. - Hong Kong Guoyuan Group Capital Holdings Limited held 140,350,000 shares, accounting for 16.50% of the total shareholding as of June 30, 2022[85]. - The Group has not granted any share options since the adoption of the share option scheme on June 15, 2012, up to June 30, 2022[73]. Governance and Compliance - The company has complied with the Corporate Governance Code, except for code provision C.1.2 regarding monthly updates to all Board members[116]. - The audit committee has reviewed the accounting principles and policies adopted by the Group and discussed financial reporting matters for the period[122]. - The interim financial report was authorized for publication by the Board of Directors on August 31, 2022[147]. Inventory and Production - Total inventories as of June 30, 2022, amounted to RMB 70,899,000, a decrease of 46.94% from RMB 133,547,000 as of December 31, 2021[200]. - Raw materials inventory decreased to RMB 40,192,000 as of June 30, 2022, down 49.83% from RMB 79,809,000 as of December 31, 2021[200]. - Finished goods inventory decreased to RMB 9,945,000 as of June 30, 2022, down 70.24% from RMB 33,398,000 as of December 31, 2021[200].
中科生物(01237) - 2021 - 年度财报
2022-04-28 13:01
Financial Performance - Revenue for the year ended December 31, 2021, was RMB 608,074,000, an increase of 23.4% compared to RMB 492,589,000 in 2020[10] - Gross profit for 2021 was RMB 121,684,000, significantly up from RMB 7,348,000 in 2020, indicating a gross margin improvement[10] - Profit before tax from continuing operations was RMB 38,171,000, a turnaround from a loss of RMB 97,814,000 in 2020[10] - Profit for the year from continuing operations was RMB 48,324,000, compared to a loss of RMB 93,695,000 in the previous year[10] - Basic earnings per share for the year was RMB 0.057, recovering from a loss of RMB 0.128 in 2020[12] - The Group achieved a consolidated profit of RMB 47.7 million for the Reporting Year, a significant turnaround from a consolidated loss of RMB 93.1 million in 2020[19][22] - The Group's revenue increased by 23.4% year-on-year to RMB 608.1 million, while gross profit surged 16.6 times to RMB 121.7 million, resulting in a gross profit margin improvement from 1.5% to 20.0%[19][22] - Revenue from the manufacturing and sales of wooden products rose by 23.8% to RMB602.0 million, contributing 99.0% of the Group's total revenue[36] - The gross profit surged to approximately RMB121.7 million, with a gross profit margin of 20.0%, up from 1.5% in 2020[51] - Revenue from timber houses and related parts increased by 43% to RMB535.8 million, representing 88% of total sales for the reporting year[45] - Overall revenue from leisure household products decreased by 27% to RMB66.2 million, primarily due to declines in recreational and landscape garden products[46] Operational Developments - The company plans to continue focusing on market expansion and new product development to drive future growth[10] - The Group plans to establish Zhangzhou Xingruixiang Supply Chain Management Co., Limited with a registered capital of RMB 30 million to enhance sourcing and sales of construction materials in China[26][27] - The Group has shifted its focus from North America to Australia and New Zealand due to trade tensions and has ceased sales of wooden products to North America since the second half of 2020[20][23] - The establishment of Xingruixiang is expected to improve the Group's access to timber supplies and enhance its product portfolio[26][27] - The Group's marketing initiatives and pricing strategies have been positively influenced by the disruption of the global supply chain, creating favorable conditions in the Australasian markets[25][29] Expenses and Costs - Total administrative expenses increased to RMB 62,155,000 from RMB 57,269,000 in 2020, reflecting ongoing operational costs[10] - Selling and distribution expenses increased to RMB46.9 million, reflecting higher turnover and shipment volumes[54] - Administrative expenses increased to RMB 62.2 million (2020: RMB 57.3 million), primarily due to the recognition of share award expenses during the reporting year[61] - Finance costs rose to approximately RMB 1.2 million (2020: RMB 0.2 million), mainly due to an increase in bank borrowings during the reporting year[62] Governance and Compliance - The Company has complied with all applicable code provisions in the Corporate Governance Code throughout the year, enhancing transparency and accountability[97] - The Board is responsible for major decisions, including approval of key policies, overall strategies, and significant financial matters[99] - The Board consists of two executive Directors and three non-executive Directors, ensuring a balance of skills and expertise[113] - The Company has adopted a Nomination Policy for the Nomination Committee to recommend candidates for election as Directors[128] - Independent non-executive Directors provide strong independent views and ensure compliance with financial reporting requirements[120] - The Company considers all independent non-executive Directors to be independent under the guidelines set out in Rule 3.13 of the Listing Rules[121] - The Board is committed to maintaining high standards of corporate governance and compliance with legal and regulatory requirements[110] Risk Management - The Risk Management Committee comprises all independent non-executive Directors, focusing on evaluating the Group's risk management framework and material risk exposures[180] - The Company acknowledges its responsibility for preparing financial statements in accordance with International Financial Reporting Standards, ensuring a true and fair presentation[184] - The Risk Management Committee will review the risks inherent in strategic transactions and provide input on risk/reward trade-offs[182] - The Company will ensure compliance with approved risk tolerance levels and policies, monitoring management's effectiveness in this regard[182] Employee and Shareholder Matters - The Group employed a total of 383 full-time employees as of December 31, 2021, compared to 340 in 2020, reflecting a growth of approximately 12.65%[88] - The Board aims to achieve diversity by considering various perspectives, including race, gender, and industry experience, in its composition[173] - The remuneration for executive Directors and senior management is determined based on performance, professional experience, and prevailing market practices[134] Audit and Financial Oversight - The Audit Committee comprises all independent non-executive Directors and is tasked with overseeing financial reporting, risk management, and internal control systems[144] - The Audit Committee reviewed the Group's internal control and financial reporting matters, including the annual results for the year ended December 31, 2020, and the interim results for the six months ended June 30, 2021, recommending approval to the Board[152] - The Audit Committee recommended the re-appointment of Ascenda Cachet CPA Limited as the external auditors of the Company[152] - The Audit Committee ensures that management has effective financial controls and risk management systems in place[152]
中科生物(01237) - 2021 - 中期财报
2021-09-24 07:25
Revenue Performance - The Group's revenue decreased by 11.9% to RMB252.1 million compared to RMB286.3 million in the same period last year[9]. - Revenue from the manufacturing and sales of wooden products was RMB249.1 million, accounting for 98.8% of total revenue, down from RMB282.9 million[14]. - The retail sales of outdoor wooden products generated no revenue during the period, compared to RMB219 thousand in the previous year[12]. - Revenue from the manufacturing and sales of renewable energy products contributed RMB3.0 million, down from RMB3.4 million[14]. - Revenue from the wooden products segment decreased by 11.9% to approximately RMB249.1 million, accounting for 98.8% of total revenue during the period[17]. - Revenue from the North America market reduced to approximately RMB54.4 million, which accounted for 22% of total revenue, down from 41% in the same period last year[29]. - Revenue from the PRC market significantly decreased to approximately RMB5.9 million, representing only 2% of total revenue, compared to 16% in the previous year[30]. - The Australasia market became the largest income source, with revenue of approximately RMB171.0 million, accounting for 68% of total revenue, up from 36% in the previous year[27]. - Revenue from timber houses and their related parts decreased by 6.6% to RMB214.9 million, representing 85.2% of total sales for the period[33]. - Overall revenue from leisure household products decreased by 11.4% to RMB34.2 million, mainly due to a decrease in sales of recreational products[35]. - Revenue from trading of timber became nil, down from RMB14.2 million in the previous year due to trade friction between China and the United States[35]. Profitability and Margins - The gross profit margin improved to 14.6%, resulting in a profit of approximately RMB4.2 million, a turnaround from a loss of RMB28.0 million in the previous year[9]. - The reportable segment profit from manufacturing and sales of wooden products was approximately RMB10.3 million, compared to a loss of RMB31.7 million in the previous year[16]. - The renewable energy business revenue decreased by 12.4% to RMB3.0 million, with a profit of approximately RMB0.4 million, consistent with the previous year[22]. - The Group recorded a profit of approximately RMB4.2 million for the period, compared to a loss of RMB28.0 million in the previous year[48]. - Gross profit for the same period was RMB36,874,000, compared to a gross loss of RMB3,637,000 in 2020, indicating a significant recovery[128]. - Profit for the period was RMB4,249,000, a turnaround from a loss of RMB27,992,000 in the previous year[130]. Market and Strategic Adjustments - The trade friction with the United States has severely impacted the Group's wooden products segment, leading to a negative gross profit margin prior to the shift in marketing focus[16]. - The Group's marketing strategy has successfully shifted to Australasia, resulting in a gross profit margin of 5.9% from this region[16]. - The Group anticipates further increases in selling costs to the United States due to new anti-dumping duties and countervailing duties[16]. - The Department of Commerce of the United States has imposed a cash deposit requirement of 54.43% on imports of relevant products from China[16]. - The Group has shifted its marketing focus to Australia due to escalating trade tensions and tariffs affecting its U.S. operations[18]. - The Group's strategy includes adjusting its business direction in the retail segment to expand its presence in the PRC household product market[21]. - The Group anticipates continued growth in the Australasian market due to strong private investment and public demand, with an estimated GDP growth of 9.5% in Australia[27]. Financial Position and Assets - As of June 30, 2021, the Group had current assets of RMB500.4 million, an increase from RMB423.3 million at the end of 2020[49]. - Total assets less current liabilities increased to RMB831,588,000 as of June 30, 2021, compared to RMB819,115,000 at December 31, 2020, reflecting a growth of 1.8%[134]. - Net assets rose to RMB824,137,000 at June 30, 2021, up from RMB812,602,000 at December 31, 2020, indicating an increase of 1.9%[134]. - Trade and other receivables rose significantly to RMB212,560,000 from RMB134,800,000, reflecting improved collection efforts[133]. - Cash and cash equivalents increased to RMB165,441,000 from RMB137,969,000, indicating better liquidity[133]. - Non-current assets decreased slightly to RMB442,647,000 from RMB455,592,000, primarily due to depreciation[133]. Shareholder Information and Corporate Governance - The Group's emolument policies are based on individual performance and are reviewed periodically, with discretionary bonuses awarded based on performance assessments[74]. - The maximum number of shares that can be granted under the Share Option Scheme is capped at 10% of the total number of shares in issue, equating to 100,000,000 shares[91]. - The Share Option Scheme was adopted to recognize contributions from eligible participants, including directors and employees[93]. - The Company has adopted a Share Award Scheme allowing for the issuance of up to 20% of the total issued shares, which amounts to 741,200,400 shares[101][102]. - The Board has resolved not to declare any interim dividend for the Period[111][114]. - The Company has complied with the Corporate Governance Code, except for code provision C.1.2 regarding monthly updates to all Board members[116][118]. Cash Flow and Financing Activities - For the six months ended June 30, 2021, the net cash used in operating activities was RMB (35,458) thousand, a significant decrease compared to RMB 66,577 thousand generated in the same period of 2020[141]. - The net cash from investing activities was RMB 4,000 thousand, recovering from a net cash used of RMB (3,905) thousand in the previous year[143]. - The net cash from financing activities increased to RMB 58,978 thousand, compared to a net cash used of RMB (22,782) thousand in the same period of 2020[143]. - The company received proceeds from new bank loans totaling RMB 57,070 thousand, a substantial increase from RMB 7,801 thousand in the prior year[143]. - The total cash and cash equivalents at June 30, 2021, amounted to RMB 165,441 thousand, up from RMB 116,274 thousand at the end of the previous year[143]. Taxation and Compliance - Current tax for the six months ended June 30, 2021, was RMB 120,000, compared to RMB 129,000 in 2020, showing a minor decrease of about 7%[197]. - Deferred tax expense for the six months ended June 30, 2021, was RMB 1,052,000, compared to a credit of RMB 728,000 in 2020, indicating a significant change in tax position[197]. - The Group's other PRC subsidiaries are subject to a corporate income tax rate of 25%[198]. - Zhangping Kimura is entitled to a preferential income tax rate of 15% for the period from 2019 to 2021 due to its qualification as a High and New Technology Entity[199].
中科生物(01237) - 2020 - 年度财报
2021-04-27 04:03
Financial Performance - The Group's revenue for the year ended December 31, 2020, was approximately RMB 492.6 million, representing a decline of 29.0% compared to RMB 694.1 million in 2019[10][15] - The Group recorded a loss of RMB 93.1 million for the year, an increase of approximately 44.4% from the loss of RMB 64.5 million in 2019[10][15] - The Group's gross profit for 2020 was RMB 4.4 million, a significant decline from RMB 8.6 million in 2019[10] - The loss per share for the year was RMB 0.128, compared to RMB 0.104 in 2019[10] - Total revenue decreased by 29.0% to RMB492.6 million in 2020, down from RMB694.1 million in 2019[30] - Revenue from the manufacturing and sales of wooden products, the largest business segment, decreased by 29.3% due to reduced demand from North American clients[31] - Revenue from timber houses and their related parts and structures decreased by 34.1% to RMB374.0 million, primarily due to anti-dumping investigations affecting sales to North America[39] - Revenue from leisure household products increased by 25.5% to RMB90.6 million, driven by higher sales of landscape garden products[40] - Gross profit decreased to approximately RMB4.4 million, with a gross margin of 0.9%, down from 1.2% in 2019, mainly due to increased sales discounts[43] - Other revenue decreased to RMB17.6 million, primarily due to a reduction in government subsidies to RMB10.0 million from RMB18.2 million in 2019[51] Assets and Liabilities - Total assets as of December 31, 2020, amounted to RMB 878.9 million, a decrease from RMB 981.4 million in 2019[12] - Total liabilities decreased to RMB 66.3 million in 2020 from RMB 95.8 million in 2019[12] - Total equity as of December 31, 2020, was RMB 812.6 million, down from RMB 885.6 million in 2019[12] - As of December 31, 2020, the Group had current assets of RMB 423.3 million, down from RMB 455.0 million in 2019, with bank deposits and cash totaling RMB 142.6 million, an increase from RMB 83.6 million in 2019[58] - The Group's total available banking facilities amounted to RMB 97.7 million as of December 31, 2020, down from RMB 151.7 million in 2019, with utilized banking facilities of RMB 27.5 million[59] - The current ratio and quick ratio as of December 31, 2020, were 7.1:1 and 5.2:1, respectively, compared to 6.0:1 and 3.0:1 in 2019[60] Expenses - Selling and distribution expenses decreased to RMB 21.7 million in 2020 from RMB 25.6 million in 2019[10] - Administrative expenses increased to RMB 57.7 million in 2020 compared to RMB 48.3 million in 2019[10] - Finance costs decreased to approximately RMB 0.2 million from RMB 1.8 million, attributed to a reduction in bank borrowings[48] - The Group recorded an other net loss of RMB 36.2 million for the period, an increase from RMB 4.7 million in 2019, primarily due to impairment of construction in progress amounting to RMB 24.6 million[52] - Sales and distribution expenses for the period were RMB 21.7 million, down from RMB 25.6 million in 2019, mainly due to a decline in revenue and shipment volume[53] - Administrative expenses increased to RMB 57.7 million from RMB 48.3 million in 2019, primarily due to share-based payment expenses of RMB 5.8 million recognized during the year[54] Market and Regulatory Environment - The U.S. Department of Commerce found that exporters received countervailable subsidies at rates from 13.61% to 245.34% for wood products from China[19] - The Group's wholly-owned subsidiary, Zhangping Kimura Forestry Products Co., Ltd., was determined to have a dumping margin of 79.4% for certain wood products exported to the U.S.[20] - The Group has ceased exports of affected products to U.S. customers starting August 2020 due to preliminary determinations[20] - The Group plans to focus on markets outside the United States and will continue to monitor developments in overseas markets[21] - The Group expects that U.S. trade measures against China will not significantly change under the new government[21] Employment and Governance - As of December 31, 2020, the company employed a total of 340 full-time employees, a decrease from 464 in 2019[85] - The company has adopted a Share Award Scheme, awarding a total of 42,550,000 Award Shares to 12 selected participants to incentivize and retain talent[87] - The company has complied with all applicable code provisions in the Corporate Governance Code throughout the year, except for certain disclosed deviations[95] - The Board consists of two executive Directors and three non-executive Directors, ensuring a balanced governance structure[111] - The Board held only two regular meetings during the year, which is below the required minimum of four meetings[106] Committees and Compliance - The Audit Committee comprises all independent non-executive Directors and is tasked with overseeing financial reporting, risk management, and internal control systems[142] - The Board has established four committees, including the audit committee, remuneration committee, nomination committee, and risk management committee, to oversee specific aspects of the Company's affairs[141] - The Audit Committee is responsible for monitoring the external auditor's independence and effectiveness of the audit process, ensuring compliance with applicable standards[149] - The Audit Committee reviewed the financial statements for the year ended December 31, 2019, and the interim results for the six months ended June 30, 2020, recommending approval to the Board[150] - The Remuneration Committee reviewed the remuneration policy and structure for executive Directors and senior management, providing recommendations to the Board[157] Risk Management - The Risk Management Committee comprises all independent non-executive Directors, focusing on evaluating the Group's risk management framework and policies[180] - The Risk Management Committee has reviewed material risk exposures, including market, credit, and operational risks, to monitor and control such exposures[182] - The Company acknowledges its responsibility for preparing financial statements in accordance with International Financial Reporting Standards[184] - There are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern[185]
中科生物(01237) - 2020 - 中期财报
2020-09-17 02:22
Financial Performance - The Group's revenue decreased by 25.4% to RMB 286.3 million compared to RMB 384.0 million in the same period last year[10]. - The Group recorded a net loss of RMB 28.0 million, worsening from a loss of RMB 14.7 million in the previous year[10]. - Gross profit margin fell to -1.3% from 3.5% year-on-year[8]. - The overall revenue for the Group decreased by 25.4% to RMB 286.3 million compared to RMB 384.0 million in the same period last year[27]. - The loss in the manufacturing and sales of wooden products segment expanded to approximately RMB 31.7 million, compared to RMB 20.4 million in the previous year[20]. - The company reported a loss for the period of RMB 27,992,000 for the six months ended June 30, 2020, compared to a loss of RMB 14,673,000 in the same period of 2019, representing an increase in loss of approximately 90.5%[134]. - Total comprehensive income for the period was RMB (27,118,000), compared to RMB (16,318,000) in the prior year, indicating a decline of approximately 66.1%[134]. - Loss from operations increased to RMB 26,922,000, up from RMB 13,831,000 in the same period last year[132]. - Loss before taxation was RMB 28,591,000, compared to RMB 16,101,000 in the prior year[132]. Revenue Breakdown - Revenue from the manufacturing and sales of wooden products decreased by 25.6% to approximately RMB 282.9 million, contributing 98.8% of total revenue[15]. - Revenue from timber houses and related parts decreased significantly, with revenue dropping to RMB 230.1 million from RMB 317.4 million[8]. - Revenue from renewable energy products remained stable at approximately RMB 3.4 million, with a profit of approximately RMB 0.4 million[22]. - The North American market revenue dropped by 44.3% to RMB 118.4 million, representing 41% of total revenue, down from 55% in the previous year[27]. - Revenue from the PRC market fell by 19.7% to RMB 45.8 million, representing 16% of total revenue, compared to 15% in 2019[30]. - Australasia market became the second largest income stream, accounting for 36% of total revenue, with a 15.6% increase in revenue to RMB 102.9 million[31]. - Revenue from outdoor wooden products decreased to RMB 282,900,000 in the first half of 2020, down 25.7% from RMB 380,354,000 in the same period of 2019[166]. - Revenue from renewable energy products was RMB 3,398,000 in the first half of 2020, slightly down from RMB 3,436,000 in the same period of 2019[166]. Cost Management - Administrative expenses decreased to RMB 20.2 million, reflecting tightened cost control measures[47]. - Administrative expenses decreased to RMB 20.2 million, down from RMB 22.5 million in the first half of 2019, due to enhanced cost control measures[53]. - Financing costs reduced to approximately RMB 0.7 million, compared to RMB 2.0 million in the first half of 2019, primarily due to a decrease in bank borrowings[54]. Market Conditions - The Group's operating results were impacted by intensified trade conflicts[10]. - The U.S. Department of Commerce announced countervailable subsidies for wood products imported from China ranging from 13.61% to 245.34%[17]. - The Group plans to enhance product competitiveness and monitor market trends closely due to adverse impacts from Sino-U.S. trade disputes[27]. - The Group anticipates that 2020 will be filled with difficulties and challenges due to the COVID-19 pandemic and geopolitical tensions, prompting a review of business strategies[76]. Assets and Liabilities - Current ratio improved to 5.5:1 from 5.1:1 in the previous year[8]. - Quick ratio increased to 3.8:1 from 2.6:1 year-on-year[8]. - Current assets as of June 30, 2020, amounted to RMB 445.0 million, slightly down from RMB 455.0 million as of December 31, 2019[58]. - Total available banking facilities increased to RMB 324.3 million as of June 30, 2020, up from RMB 237.2 million as of December 31, 2019[59]. - Non-current assets decreased from RMB 526,472,000 as of December 31, 2019, to RMB 514,180,000 as of June 30, 2020, a reduction of about 2.5%[137]. - The company's equity decreased from RMB 885,633,000 at the end of 2019 to RMB 871,689,000 as of June 30, 2020, a reduction of about 1.6%[138]. Employee and Corporate Governance - As of June 30, 2020, the total number of employees decreased to 284 from 535 in June 2019, indicating a reduction in workforce[86]. - The company emphasizes automation in production processes and staff training to enhance competitiveness[86]. - The company has a competitive salary package and contributes to social insurance for its employees[87]. - The Company has complied with the principles set out in the Corporate Governance Code, except for code provision C.1.2[120]. Shareholder Information - As of June 30, 2020, Mr. Wu Zheyan holds a long position of 89,929,482 shares, representing approximately 12.13% of the company's shares[95]. - The entire issued share capital of Green Seas Capital Limited is owned by Mr. Wu Zheyan, linking him to the shares held[106]. - Hong Kong Run De Holdings Limited and its controlled corporation hold 86,000,000 shares, accounting for 11.60% of the total shareholding[100]. - Hong Kong Guoyuan Group Capital Holdings Limited has a significant interest with 140,350,000 shares, which is 18.59% of the total[101]. Cash Flow and Investments - Cash generated from operations for the six months ended June 30, 2020, was RMB 66,577,000, a decrease of 9% from RMB 73,153,000 in 2019[145]. - The net cash used in investing activities was RMB 3,905,000 for the six months ended June 30, 2020, compared to RMB 10,192,000 in 2019, indicating a reduction in cash outflow[145]. - The company recorded a net increase in cash and cash equivalents of RMB 39,890,000 for the six months ended June 30, 2020, compared to an increase of RMB 13,606,000 in 2019[146]. - As of June 30, 2020, cash and cash equivalents totaled RMB 116,274,000, up from RMB 51,623,000 at the end of the same period in 2019[146].
中科生物(01237) - 2019 - 年度财报
2020-04-27 22:37
Financial Performance - Revenue for the year ended December 31, 2019, was RMB 694,052,000, an increase of 9.4% from RMB 634,686,000 in 2018[8] - Gross profit decreased significantly to RMB 8,624,000, resulting in a gross profit margin of 1.2%, down from 10.8% in the previous year[8] - The net loss for 2019 was RMB 64,471,000, improving from a net loss of RMB 184,931,000 in 2018, with a net profit margin of -9.29%[8] - The Group recorded a loss of RMB 64.5 million for the year, a significant decrease from the loss of approximately RMB 184.9 million in 2018, primarily due to no significant additional impairment of assets required in 2019[18] - The impairment of assets recognized in 2018 amounted to approximately RMB 139.3 million, which was not repeated in 2019[18] - The Group anticipates challenges in profitability due to external factors such as the global economic slowdown and the COVID-19 outbreak[23] - The Group's overall profitability is expected to be under pressure due to various unfavorable external and domestic factors affecting asset and inventory returns[25] Assets and Liabilities - Current assets decreased to RMB 454,973,000 from RMB 618,361,000 in 2018, while current liabilities reduced to RMB 89,234,000 from RMB 197,862,000[8] - Total assets as of 31 December 2019 were RMB 981.4 million, down from RMB 1,167.9 million in 2018[15] - Total liabilities decreased to RMB 95.8 million in 2019 from RMB 217.3 million in 2018[15] - Non-current assets decreased to RMB 526,472,000 from RMB 549,520,000 in 2018, reflecting a reduction in long-term investments[8] - The equity attributable to equity shareholders decreased to RMB 885,633,000 from RMB 950,548,000 in 2018, indicating a decline in shareholder equity[8] Revenue Breakdown - The manufacturing and sales of wooden products generated revenue of approximately RMB 687.1 million, an increase of 11.0% from RMB 618.9 million in 2018, accounting for 99.0% of total revenue[29][30][33] - Revenue from the renewable energy products segment decreased by 52.7% to approximately RMB 6.9 million, down from RMB 14.6 million in 2018, with profit dropping to RMB 0.9 million from RMB 2.5 million[29][36] - Revenue from North America grew by 28.6% to RMB334.4 million, accounting for 48% of total revenue, up from 41% in 2018[40][41] - Revenue from the PRC market fell by 23.6% to RMB111.6 million, representing 16% of total revenue, down from 23% in 2018[43][45] - Overall revenue from leisure household products surged by 36.9% to RMB72.1 million, with outdoor and indoor furniture increasing by 90.7%[49][53] Market Challenges - The increase in trade tariffs imposed by the United States from 10% to 25% effective May 2019 further declined the profit margin of wooden products exported to the U.S.[19] - The North American market remains the largest income stream for the Group, but trade tensions have adversely impacted performance[19] - The Group anticipates that external factors, including the COVID-19 outbreak and economic slowdowns, will negatively impact profitability in the first half of 2020[25] Corporate Governance - The company has complied with all applicable corporate governance code provisions throughout the year, except for certain disclosed deviations[109] - The Board of Directors is responsible for major decisions, including overall strategies and annual budgets, and is expected to meet at least four times a year[111][122] - The Board consists of two executive directors and four non-executive directors, with three of the non-executive directors being independent[125] - The company is committed to maintaining high standards of corporate governance to enhance transparency and accountability to shareholders[108] Employee and Remuneration - Total employee remuneration expenses for the year were RMB35.3 million, representing 5.1% of the Group's revenue[95] - The Group employed 464 full-time employees as of December 31, 2019, an increase from 426 in 2018[95] - The remuneration for executive Directors and senior management is determined based on performance, professional experience, and prevailing market practices[147] Risk Management - The Risk Management Committee, comprising all independent non-executive Directors, is responsible for reviewing the Group's risk management framework and material risk exposures[196][198] - The Directors acknowledge their responsibility for preparing financial statements that present a true and fair view in accordance with International Financial Reporting Standards[200] COVID-19 Impact - The outbreak of COVID-19 in January 2020 may impact the Group's financial results, although the extent cannot be estimated at this time[104] - The Group will take proactive measures to minimize the impact of COVID-19 on its financial position and operating results[104] - The ongoing COVID-19 pandemic may further affect the company's financial performance, although the extent of this impact is currently unquantifiable[106]
中科生物(01237) - 2019 - 中期财报
2019-09-20 09:09
Financial Performance - The Group achieved a revenue growth of 13.3% to RMB 384.0 million compared to RMB 314.0 million in the same period last year[12]. - The gross profit decreased significantly to RMB 13.3 million, resulting in a gross profit margin of 3.5%, down from 17.4% in the previous year[12]. - The Group recorded a net loss of RMB 14.7 million, compared to a profit of RMB 10.5 million in the same period last year, leading to a net profit margin of -4.0%[12]. - The overall revenue from all business segments amounted to approximately RMB 384.0 million, a 22.3% increase from RMB 313.9 million in the previous year[29]. - The Group recorded a loss of approximately RMB 14.7 million for the period, compared to a profit of RMB 10.5 million in H1 2018[52]. - Loss for the period was RMB 14,673,000, a significant decline from a profit of RMB 10,518,000 in the same period of 2018[131]. - Total comprehensive loss for the period was RMB 16,318,000, compared to a total comprehensive income of RMB 10,311,000 in the previous year[131]. Revenue Breakdown - Revenue from the manufacturing and sales of wooden products increased by 25.2% to RMB 380.4 million, contributing 99.0% of the total revenue[21]. - Revenue from timber houses and related parts was RMB 317.4 million, a significant increase from RMB 230.7 million in the previous year[12]. - Revenue from the renewable energy segment decreased by 63.7% to approximately RMB 3.4 million, with profit down to RMB 0.45 million[24]. - The retail business segment generated revenue of RMB 0.22 million, a decrease of 73.4% compared to RMB 0.82 million in the previous year[18]. - Revenue from the PRC market fell by 28.8% to RMB 57.1 million, accounting for 15% of total revenue[29]. - North America accounted for 55% of the total revenue, with revenue growing by 60.6% to RMB 212.6 million[29]. - Revenue from the China market decreased by 63.9% to RMB 29.0 million, representing 15% of total revenue, down from 26% in H1 2018[31]. - Australasia market maintained its position as the second largest income stream, contributing 23% of total revenue, with a 21.0% growth to RMB 89.0 million[33]. Asset Management - Non-current assets stood at RMB 546.9 million, while current assets decreased to RMB 513.3 million[12]. - The current ratio improved to 4.9:1 from 3.1:1, indicating better short-term financial health[12]. - Inventory turnover days decreased to 165 days from 218 days, reflecting improved inventory management[12]. - Trade receivables turnover days improved to 54 days from 65 days, indicating faster collection of receivables[12]. - Current assets decreased to RMB 513,272,000 from RMB 618,361,000 at the end of 2018, reflecting a decline of 18.0%[133]. - Total equity as of June 30, 2019, was RMB 934,230,000, down from RMB 950,548,000 at the end of 2018[134]. Operational Challenges - The Group's operating results were impacted by intensified trade conflicts, affecting overall profitability[15]. - The US-China trade dispute has negatively impacted the gross profit margin of the Group's products exported to the United States[22]. - The trade dispute between the US and China has created significant uncertainty and adverse impacts on the Group's business prospects, particularly affecting profit margins on products exported to the US[72]. - The Group plans to enhance product competitiveness and monitor market trends closely due to expected adverse effects on profitability[29]. Cost Management - Administrative expenses decreased to RMB 22.5 million, down from RMB 25.3 million in H1 2018, due to tightened cost control[49]. - The Group's financing costs decreased to approximately RMB 2.0 million during the period, down from RMB 3.8 million in the first half of 2018[56]. Capital Expenditure and Financing - Capital expenditure for property, plant, and equipment during the period was RMB 10.8 million, an increase from RMB 4.3 million in the first half of 2018[61]. - The total bank financing available to the Group was RMB 226.4 million as of June 30, 2019, compared to RMB 237.2 million at the end of 2018[59]. - The Group had no significant capital commitments or contingent liabilities as of June 30, 2019[62]. Shareholding and Corporate Governance - As of June 30, 2019, Mr. Wu Zheyan holds 449,647,412 shares, representing a 14.56% interest in the company[94]. - The Company has complied with the principles set out in the Corporate Governance Code, except for code provision C.1.2[115]. - The Board has resolved not to declare any interim dividend for the Period[114]. Accounting Policies and Standards - The company has maintained its accounting policies consistent with those adopted in the 2018 annual financial statements, with expected changes to be reflected in the 2019 annual financial statements[142]. - The group adopted IFRS 16, which requires all leases to be capitalized, excluding short-term leases and low-value asset leases[162]. - The initial application of IFRS 16 was effective from January 1, 2019, with the cumulative effect recognized as an adjustment to the opening balance of equity[155]. - The auditor's report on the financial statements was unqualified, indicating no significant issues were raised[148].
中科生物(01237) - 2018 - 年度财报
2019-04-18 08:49
Financial Performance - Revenue for 2018 reached RMB 634,686,000, a 37.2% increase from RMB 462,191,000 in 2017[10] - Gross profit for 2018 was RMB 68,525,000, with a gross profit margin of 10.8%, up from 7.0% in 2017[10] - The net loss for 2018 was RMB 184,931,000, resulting in a net profit margin of -29.1%, compared to -8.8% in 2017[10] - The loss attributable to shareholders increased to RMB 185 million in 2018, up from RMB 40.6 million in 2017, primarily due to weakened profitability from exports and asset impairment[18] - The Group recorded a net loss of RMB 184.9 million for the year, compared to a loss of RMB 40.6 million in 2017, reflecting a significant increase in losses[66] Asset Management - Non-current assets decreased to RMB 549,520,000 in 2018 from RMB 772,335,000 in 2017[10] - Current assets also declined to RMB 618,361,000 in 2018 from RMB 721,148,000 in 2017[10] - Total assets decreased to RMB 1,167,881 thousand in 2018 from RMB 1,493,483 thousand in 2017, while total liabilities decreased to RMB 217,333 thousand from RMB 362,893 thousand[16] - The Group recognizes the need for asset impairment of production facilities and lease prepayments due to ongoing trade tensions affecting profitability[36] Financial Ratios - The current ratio improved to 3.1:1 in 2018 from 2.2:1 in 2017, indicating better short-term financial health[10] - Total borrowings to total assets ratio decreased to 9.3% in 2018 from 16.7% in 2017, indicating reduced leverage[10] - The ratio of total borrowings to total assets was 9.3%, down from 16.7% in 2017, while the current ratio improved to 3.1:1 from 2.2:1[75] Revenue Breakdown - The manufacturing and sales of wooden products generated revenue of approximately RMB618.9 million, an increase of 41.7% from RMB436.8 million in 2017, accounting for 97.5% of total revenue[31] - Revenue from renewable energy products decreased by 27.5% to approximately RMB14.6 million, with profit declining by 29.1% to approximately RMB2.5 million, primarily due to intense domestic competition[38] - Revenue from the North American market grew by 10.1% to RMB260.1 million, accounting for 41% of total revenue (2017: 51%)[44] - Revenue from the PRC market increased by 36.1% to RMB146.1 million, representing 23% of total revenue, driven by growth in timber trading[43] - Australasia market revenue surged by 125.5% to RMB187.9 million, now accounting for 29% of total revenue (2017: 18%)[46] Market Challenges - The US-China trade dispute led to a 10% tariff on 5,745 types of imported goods, significantly impacting the Group's export business to the US[19] - The Group anticipates continued challenges in 2019 due to uncertainties from the US-China trade war and economic conditions in overseas markets[24] - The group anticipates continued challenges in the operating environment for 2019, influenced by the US-China trade dispute and other global economic uncertainties[27] Operational Strategies - The company plans to focus on expanding its renewable energy product line and enhancing its market presence[10] - New product development initiatives are underway to improve the range of leisure household products and timber-related offerings[10] - The retail business aims to improve operations through better cost controls and potential realignment of business direction[40] Employee Management - The Group employed a total of 426 full-time employees as of December 31, 2018, down from 510 in 2017[99] - Total employee compensation expenses for the year amounted to RMB 35.5 million, up from RMB 32.6 million in 2017, representing 5.6% of the group's revenue compared to 7.1% in 2017[102] - The company has maintained a competitive compensation package for employees, including discretionary bonuses and social insurance contributions[102] Corporate Governance - The board of directors consists of two executive directors and four non-executive directors, with three non-executive directors being independent[122] - The company has complied with all applicable code provisions in the Corporate Governance Code throughout the year, except for certain disclosed deviations[106] - The Audit Committee is responsible for overseeing financial reporting, risk management, and internal control systems, and is composed of independent non-executive Directors[154][158] Risk Management - The Risk Management Committee is composed entirely of independent non-executive directors, focusing on risk management and oversight of the company's risk policies and standards[192] - The committee reviews the group's major risk exposures, including market, credit, operational, and liquidity risks, ensuring compliance with risk measurement methodologies[194] - The company acknowledges its responsibility for preparing financial statements that present a true and fair view in accordance with International Financial Reporting Standards[196]